Autopsy report · NCT03717038

Sym004 Versus TAS-102 in Patients With mCRC

“Study was withdrawn due to administrative reasons”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 3

Sponsor

Symphogen A/S

Sponsor type

Industry

Conditions

Metastatic Colorectal Cancer; Colorectal Cancer Metastatic; Carcinoma

Interventions

Sym004; TAS-102

Participants

0

Trials that died the same way

• Maxi-Analgesic Osteoarthritis (OA) Study
  “The study was withdrawn for administrative reason” (97% match in meaning)
• A Study of the Safety and Efficacy of Pancreatic Endocrine Cell Clusters Implanted Into the Omentum of Type 1 Diabetes Patients With Severe Hypoglycemia
  “Study is being withdrawn for business reasons” (87% match in meaning)
• Sym004 Versus Futuximab or Modotuximab in Patients With mCRC
  “Study was terminated due to administrative reasons” (87% match in meaning)
• Dose Ranging Study to Evaluate the Efficacy and Safety of MEDI8852 in Adults Who Are Hospitalized With Type A Influenza.
  “Study is withdrawn due to company decision.” (84% match in meaning)
• DELPhI Evaluation of Psychiatric Conditions
  “Study was withdrawn due to recruitment difficulties” (83% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.